SY Pharmtech to run technology transfer business.

While the government mulls a third party (toll) manufacturing permission for pharmaceutical products, SY pharmtech (president: Choi Soo-young) announced on Feb. 2 that the company is trying to run a technology transfer business with new drugs to the domestic manufacturers and wholesalers under the foreign business partners of the United States, UK, Russia and India

SY Pharmtech has made an e...